Literature DB >> 62796

Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect.

A Ahmed, I Scher.   

Abstract

Minor lymphocyte-stilulating (MIs) coded non-H-2-linked lymphocyte-activating determinants (LADs) are present on a late developing subpopulation of murine B lymphocytes. Spleen cells derived from CBA/N mice, a strain with an X-linked defect in B cell function, failed to stimulate a response in MIs-defined mixed lymphocyte reactions (MLRs) with H-2 identical CBA/J or C3H/N responder spleen cells. However, both CBA/J and C3H/N spleen cells induced significant responses in CBA/N responder spleen cells. The inability of CBA/N cells to induce an MIs-defined response was not due to the presence of the nonstimulatory MIsb genotype, since spleen cells of immunologically normal F1 mice derived from crosses of CBA/N and C3H/N mice were stimulatory in MLRs for C3H/N responder cells. Immunologically abnormal CBA/N female x C3H/N male) F1 male mice, which are hemizygous for the CBA/N X chromosome, were also unable to induce a response in MIs-defined MLRs. Although the MIs coded LADs are not X linked in immunologically normal mouse strains, these data indicate that the failure of CBA/N mice to functionally express the MIs-coded LADs is X linked. This characteristic was not secondary to the presence of suppressor cells and is most likely related to the absence of a late developing (mature) subpopulation of B lymphocytes in these mice.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62796

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  DBA/2J (Mls-1a) B-cell differentiation in BALB.xid recipients.

Authors:  K Tocce; K Suppiah; C Rago; R Liberchuk; K Duffy; J Riggs
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.

Authors:  J J Ryan; H B LeJeune; J J Mond; F D Finkelman
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Genetic linkage between Lym-1, Sas-1 and Mls loci.

Authors:  H B Dickler; D L Rosenstreich; A Ahmed; D H Sachs
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

4.  Induction of partial chimerism in nonirradiated B-lymphocyte-deficient CBA/N mice.

Authors:  D Volf; L L Sensenbrenner; S J Sharkis; G J Elfenbein; I Scher
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

5.  B-lymphocyte Fc receptor-associated non-H-2 antigens are determined by a single polymorphic locus which is linked to the Mls locus.

Authors:  H B Dickles; A Ahmed; D H Sachs
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

6.  Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity.

Authors:  R Schneider; R K Lees; T Pedrazzini; R M Zinkernagel; H Hengartner; H R MacDonald
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

7.  Susceptibility to in vitro tolerance induction of adult B cells from mice with an X-linked B-cell defect.

Authors:  E S Metcalf; I Scher; N R Klinman
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

8.  Lack of mature B cells in nude mice with X-linked immune deficiency.

Authors:  H H Wortis; L Burkly; D Hughes; S Roschelle; G Waneck
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

9.  Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus.

Authors:  O Mazda; Y Watanabe; J Gyotoku; Y Katsura
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Development of B lymphocytes in mice heterozygous for the X-linked immunodeficiency (xid) mutation. xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow.

Authors:  L M Forrester; J D Ansell; H S Micklem
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.